Study of Becotatug Vedotin Added to Standard Treatment for Advanced Bile Duct Cancer With EGFR Mutations
Clinical trial NCT07598318 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07598318
- Sponsor
- Sir Run Run Shaw Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-20
- Primary completion
- 2027-12-31
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.